7.50
+0.03
+(0.43%)
At close: January 31 at 8:00:44 AM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BENZENO SHARON Officer | Sale | Mar 5, 2024 | 327,415 |
| BOBULSKY SUSAN Officer | Conversion of Exercise of derivative security | Oct 8, 2024 | 253,290 |
| GRIFFIN MICHELLE RENEE Director | Stock Award(Grant) | Mar 4, 2024 | 51,955 |
| LO FRANCIS Officer | Sale | Mar 5, 2024 | 256,245 |
| NEUPERT PETER M Director | Conversion of Exercise of derivative security | Mar 12, 2024 | 169,296 |
| PETERSON TYCHO Chief Financial Officer | Sale | Mar 5, 2024 | 531,553 |
| PISKEL KYLE Chief Financial Officer | Sale | Nov 18, 2024 | 154,330 |
| ROBINS CHAD M Chief Executive Officer | Sale | Mar 5, 2024 | 2,576,700 |
| RUBINSTEIN JULIAN President | Sale | Mar 5, 2024 | 472,754 |
| TAYLOR STACY L General Counsel | Sale | Aug 22, 2024 | 139,365 |
Related Tickers
RGO.F Regeneron Pharmaceuticals, Inc.
655.40
-0.21%
REGN34.SA Regeneron Pharmaceuticals, Inc.
65.74
-1.81%
1MRNA.MI Moderna, Inc.
39.44
-2.13%
BEAM Beam Therapeutics Inc.
25.92
-4.99%
SANA Sana Biotechnology, Inc.
3.2200
-7.74%
DNA Ginkgo Bioworks Holdings, Inc.
13.36
-3.95%
DWTX Dogwood Therapeutics, Inc.
12.49
-2.12%
CRSP CRISPR Therapeutics AG
41.59
-1.07%
AKRO Akero Therapeutics, Inc.
54.08
-2.31%
MRNA Moderna, Inc.
39.42
-3.95%